NCT01165333 2026-03-16
CILENT
Centre Oscar Lambret
Phase 1 Completed
Clinical Trials
8 trialsNCT06489041 2026-02-02
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Wake Forest University Health Sciences
Phase NA Recruiting
NCT06744712 2026-01-07
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Wake Forest University Health Sciences
Phase NA Not yet recruiting
NCT01196936 2026-01-05
LDTam
University of Alabama at Birmingham
Phase 2 Active not recruiting
NCT01479842 2025-10-15
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT05830279 2025-07-09
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Recruiting
NCT02399371 2025-06-11
Pembrolizumab in Treating Patients With Malignant Mesothelioma
University of Chicago
Phase 2 Active not recruiting
NCT06511401 2025-04-27
C-PAIN
University of Chicago
Phase NA Recruiting